Adoptive Transfer of Haplo-identical DLI for AML and MDS

Clinical trial NCT02046122 · COMPLETED

Trial details

NCT number: NCT02046122
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome

Start date: 2014-07-01
Primary completion: 2017-06-15
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.